Location: Home
  • search
  • go
  • Relate News
  • 5/12/2026CureGene Raises Over CNY 300M in Series C Led by Walvax
  • 5/12/2026China Approves Novel EGFR, JAK2 Therapies as Wave of Innovative INDs A...
  • 5/12/2026BMS Strikes Up to $15.2B Hengrui Alliance to Accelerate Global Drug De...
  • 5/12/2026China Holds National Healthcare Reform Meeting, Prioritizes Public Hos...
  • 5/12/2026China Expands National Pediatric Medical Center Network to Strengthen ...
  • 5/12/2026China Moves to Expand Maternity Insurance Coverage and Birth-Related B...
  • 5/12/2026Sihuan Pharma Completes Full H-Share Conversion of Xuanzhu Biopharm
  • 5/12/2026BrightGene Reports Phase 3 Success for Dual GLP-1/GIP Obesity Drug BGM...
  • 5/12/2026Virax Eyes China Expansion for T-Cell Immune Profiling Platform
  • 5/12/2026Singapore, China Expand Regulatory Partnership to Include Gene and Cel...
  • 5/11/2026NHC Seeks Comments on Revised Human Genetic Resources Regulation Imple...
  • 5/11/2026Bundxcell Completes A+ Financing to Advance iPSC-Based Regenerative Me...
  • 5/11/2026NHSA Seeks Comments on 2026 NRDL and Commercial Innovation Drug List A...
  • 5/11/2026NMPA Releases 105th Batch of Generic Drug Reference Formulations
  • 5/11/2026CDE Releases Draft MSC Stem Cell Product Guideline for Public Consulta...
  • 5/11/2026China Emerges as Global Hub for siRNA Out-Licensing Deals: PharmaDJ
  • 5/8/2026LTZ Thera Raises $38M to Advance Myeloid-Engager Immunotherapy Pipelin...
  • 5/8/2026InnoCare Advances CDH17 ADC Into Clinic as Competition Builds in GI Ca...
  • 5/8/2026China Poised to Lead Next Wave of CAR-T Innovation in Solid Tumors, Sa...
  • 5/8/2026Viatris Tops Quarterly Estimates on Strong China Performance and Brand...
  • 5/8/2026China Unveils Tougher Nationwide Rules Governing Medical Representativ...
  • 5/8/2026China Reports 3.05M ADRs in 2025, Flags Oncology and Anti-Infective Ri...
  • 5/8/2026CDE Issues Revised Technical Guideline for Recombinant Insulin Product...
  • 5/8/2026Recent Executive Moves
  • 5/7/2026Amgen Wins China Approval for Evenity (Romosozumab)
  • 5/7/2026GSK Expands China Biotech Push With Up to US$1 Billion siRNA Obesity D...
  • 5/7/2026Novo Nordisk Signals Delays for Ozempic Generics in China Despite Pate...
  • 5/7/2026Sino Biopharm Wins China Approval for World's First CDK2/4/6 Inhibitor...
  • 5/7/2026InnoCare Secures China IND Approval for Novel CDH17-Targeted ADC ICP-B...
  • 5/7/2026ZTE Partners With China's National Clinical Research Center for Interv...
  • Page:5/836 Total number of articles:25069: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group